Source BioScience Expanding Next-Gen Sequencing Services, Moving into Cancer Dx

The company expects revenues for its next-gen sequencing business to double this year, surpassing its capillary electrophoresis sequencing business.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.